Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Value, Access and Regulatory Strategy Workshop
Session 7: Relative Efficacy versus Relative Effectiveness – the Future
Session Chair(s)
François Meyer, MD
- Advisor to the President, International Affairs
- French National Authority for Health (HAS), France
- Current challenges in the assessment of relative efficacy/effectiveness
- The need for comparative data
- Role of EUnetHTA moving forward
- Cooperation between EMA and EUnetHTA: current status and perspectives
Speaker(s)
Leeza Osipenko, PhD, MSc
- Head of Scientific Advice
- National Institute for Health and Care Excellence (NICE), United Kingdom
Kristin Svanqvist, MPharm
- Governmental Affairs Manager
- Amgen, Norway
Michael Berntgen, PhD
- Head of Scientific Evidence Generation
- European Medicines Agency, Netherlands